A7RC peptide modified paclitaxel liposomes dually target breast cancer. - Wikidata - awgldk - TriplyDB

A7RC peptide modified paclitaxel liposomes dually target breast cancer.

A7RC peptide modified paclitaxel liposomes dually target breast cancer.

http://www.wikidata.org/entity/Q38842323

about

Therapeutic Potential of Delivering Arsenic Trioxide into HPV-Infected Cervical Cancer Cells Using Liposomal Nanotechnology Effects of local structural transformation of lipid-like compounds on delivery of messenger RNA.Sustained release of anticancer agent phytic acid from its chitosan-coated magnetic nanoparticles for drug-delivery system Multifunctional Gadolinium-Doped Mesoporous TiO2 Nanobeads: Photoluminescence, Enhanced Spin Relaxation, and Reactive Oxygen Species Photogeneration, Beneficial for Cancer Diagnosis and Treatment.Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy.Encapsulation of Anticancer Drugs (5-Fluorouracil and Paclitaxel) into Polycaprolactone (PCL) Nanofibers and In Vitro Testing for Sustained and Targeted Therapy.Investigation and intervention of autophagy to guide cancer treatment with nanogels.A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy Gold nanoparticles in injectable calcium phosphate cement enhance osteogenic differentiation of human dental pulp stem cells.Mucin-1-Antibody-Conjugated Mesoporous Silica Nanoparticles for Selective Breast Cancer Detection in a Mucin-1 Transgenic Murine Mouse Model.DNA Nanostructures Carrying Stoichiometrically Definable Antibodies.

P2860

Q36594617-8F396E5D-2DC7-44BF-ACC3-972161D7F384 Q38641628-816C0BEA-7D05-4A7B-97B7-24B018048161 Q38708384-D71D89F1-7341-4CFE-A681-9D8CF56E25A1 Q38735324-DB29D9AC-3064-41A0-932A-539D9409108B Q38787937-AAE14A89-EF25-463C-B494-5D5B00E8371C Q41507703-B62C48D8-5104-48F7-A040-86536A1C3A9E Q41913812-DFDF21F1-07C1-46E6-A3DE-3EB55F2EF99B Q42659386-0B8013AA-367C-45A8-97C7-D13AE331E086 Q47696906-1283A119-B6B4-4DE9-BA97-C167CFB297DC Q47759359-89D19D36-D1A4-4102-8A26-28BCBD0272AA Q51133950-37871CF7-784F-4E97-B433-7A0069919820

P2860

A7RC peptide modified paclitaxel liposomes dually target breast cancer.

http://www.wikidata.org/entity/Q38842323

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A7RC peptide modified paclitaxel liposomes dually target breast cancer.

@en

type

label

A7RC peptide modified paclitaxel liposomes dually target breast cancer.

@en

prefLabel

A7RC peptide modified paclitaxel liposomes dually target breast cancer.

@en

P1433

Q38842323-2908AAC3-EF25-42C8-8BA9-56326B636D49

P1476

Q38842323-8F2FFEF0-8286-46BD-84C9-3E292CABA0F3

P2093

Q38842323-16774870-5580-4F8D-B7B7-5EA9732A5606

Q38842323-1A8E0DA0-DE1E-44DB-96B1-6AD9B372FDA2

Q38842323-1CCFCC29-69EF-4E93-95E6-AD7407A862FC

Q38842323-237898EF-8069-48F2-AAC4-00329A28EF82

Q38842323-36F84006-F940-4DFF-9452-B5FFAAFD46A9

Q38842323-54521470-31AC-4EE9-BC46-92FF486AEE14

Q38842323-5F781512-7583-4A4D-B8F1-2A78B8AA672E

Q38842323-7089A724-C00B-4829-ABC3-9429EA83B6CE

Q38842323-729BE02A-FD9A-4BC2-B40C-76DD3C1B84BC

Q38842323-7F8406EF-F240-471B-A07B-5DF7ABB0CB14

P2860

Q38842323-03F8C8AD-A8A6-4ABF-97F7-6A7F01D7510E

Q38842323-076854F5-B2DE-4823-90EF-0B2DDF562C2E

Q38842323-096E74BB-AF9F-4F01-B61E-F51E74354CB4

Q38842323-0F10E8AC-C692-4790-A64A-8394D5010359

Q38842323-18C6A9E9-36A4-4411-8FB1-7705366FE532

Q38842323-28A229A3-D34B-49CC-8918-07C2A197E65F

Q38842323-354A7552-897E-4F38-91FE-06EF5690E3EE

Q38842323-3634AB50-5C69-471C-B9B7-ED885BD9EBD1

Q38842323-382950CE-2DF8-49C8-9ABF-0B89B00658DB

Q38842323-49D21A07-E320-4D53-8343-1D3E164B67C1

P304

Q38842323-B9AF8CFA-B1BF-475E-87D9-B9E0E1E56FCF

P31

Q38842323-C6B7E144-5211-42E7-8804-D9084BE4A8E0

P356

Q38842323-C1798D6C-DD9B-46B0-B4F5-74D850FBF92E

P433

Q38842323-E56D35C3-F65B-4A82-B429-5AC3089751B5

P478

Q38842323-5C993F31-D661-4B2D-8630-238F5BE8CA67

P577

Q38842323-6D1A34E2-5E88-48DF-968F-62C8AA4AF1B4

P698

Q38842323-D651CA96-6560-46D9-BEF0-D3D02C91E264

P356

P1433

Biomaterials Science

P1476

A7RC peptide modified paclitaxel liposomes dually target breast cancer.

@en

P2093

Chunlan Zhou

http://www.w3.org/2001/XMLSchema#string

Guangtian Wang

http://www.w3.org/2001/XMLSchema#string

Guangyu Sun

http://www.w3.org/2001/XMLSchema#string

Haisheng Peng

http://www.w3.org/2001/XMLSchema#string

Jingyan Cao

http://www.w3.org/2001/XMLSchema#string

Minghui Li

http://www.w3.org/2001/XMLSchema#string

Ning Gao

http://www.w3.org/2001/XMLSchema#string

Qun Wang

http://www.w3.org/2001/XMLSchema#string

Ran Wang

http://www.w3.org/2001/XMLSchema#string

Shukun Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth

Neuropilin is a semaphorin III receptor

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

Neuropilins: expression and roles in the epithelium

Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.

The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers.

Paclitaxel (taxol)

Tissue-penetrating delivery of compounds and nanoparticles into tumors.

The role of glucose transporters in the distribution of p-aminophenyl-α-d-mannopyranoside modified liposomes within mice brain.

Liposomal encapsulated anti-cancer drugs.

P304

1545-1554

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C5BM00161G

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26291480

http://www.w3.org/2001/XMLSchema#string